Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct effects of NSAIDs on osteoarthritic knee cartilage
NL-OMON21305Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2004
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of celecoxib, naproxen and indomethacin in knee osteoarthritis (OA), sponsored by University Medical Center Utrecht. Primary endpoint: Proteoglycan release from osteoarthritic cartilage. Started Nov 2004; status: active, not recruiting.
02
Drugs
celecoxibnaproxenindomethacin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON21305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21305.